Experienced in IgG4-Related Disease

Dr. H J. Wedner

Allergy and Immunology
Washington University Physicians
Washington University
10 Barnes W Dr, 200 Asthma And Allergy Cente, 
St Louis, MO 
Accepting New Patients

Experienced in IgG4-Related Disease
Washington University Physicians
Washington University
10 Barnes W Dr, 200 Asthma And Allergy Cente, 
St Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

H Wedner is an Allergy and Immunologist in St Louis, Missouri. Dr. Wedner is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Common Variable Immune Deficiency, Primary Immunodeficiency (PID), Bloom Syndrome, and Urticaria Pigmentosa. Dr. Wedner is currently accepting new patients.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Internal Medicine in MO
Hospital Affiliations
Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

WASHINGTON UNIVERSITY
10 Barnes W Dr, 200 Asthma And Allergy Cente, St Louis, MO 63141
Call: 314-996-8670
Other Locations
WASHINGTON UNIVERSITY
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110
Call: 314-747-3000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Enrollment Status: Completed
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drug: Lanadelumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Enrollment Status: Completed
Publish Date: December 27, 2023
Intervention Type: Other, Drug
Study Drug: Lanadelumab
Study Phase: Phase 3
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
Enrollment Status: Completed
Publish Date: September 29, 2023
Intervention Type: Biological
Study Phase: Phase 4
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: June 05, 2023
Intervention Type: Biological
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Karen E. Boone
Experienced in IgG4-Related Disease
Dr. Karen E. Boone
Otolaryngology | Allergy and Immunology
Experienced in IgG4-Related Disease
Dr. Karen E. Boone
Otolaryngology | Allergy and Immunology

Midwest Ent Centre, PC

4790 Executive Centre Pkwy, 
Saint Peters, MO 
 (10.6 miles away)
636-441-3100
Experience:
35+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

A third-generation physician, Dr. Boone began her otolaryngology practice in St. Charles County in the 1990s. Her father, Dr. James Vighi, also an otolaryngologist, practiced in the county for 25 years.  A board-certified otolaryngologist, Dr. Boone is a St. Louis native who attended Chesterfield’s Parkway Central High School before achieving a degree in biomedical engineering at Northwestern University. She received her medical degree from Case Western Reserve School of Medicine where she was a member of Alpha Omega Alpha Honor Society and recipient of the Janet M. Glasgow Memorial Achievement Award. After medical school, Dr. Boone completed her surgical internship and her otolaryngology residency at St. Louis University.  During her residency, she received several achievement awards including Cardinal Glennon department of pediatric surgery intern award given to the surgical intern who exemplifies outstanding surgical skill and patient care.  She was also awarded the Department of Otolaryngology Resident Research Award given the best resident research project judged by an guest professor.  During her residency, she published several articles ranging from newborn hearing screening to intraoperative nerve monitoring. A fellow of the American Academy of Otolaryngology, Dr. Boone is also a member of the American Academy of Otolaryngologic Allergy, St. Charles-Lincoln County Medical Society, the Missouri State Medical Association, and the American Medical Association. Dr. Boone has been an integral part in the development of the electronic medical records implementation.  She has served on the board of Allscripts for many years and is dedicated to providing the most state of art medical information transparency for her patients.   Philanthropy has been an integral part of Dr. Boone’s life. She has served on several community charity boards in the past. She presently serves as a Board of Directors for Marcy’s Project and is also involved with the St. Louis Zoo Merlin Perkins Society and the St. Louis Winter Opera. Married to Dennis Boone and mother of five children and four grandchildren, Dr. Boone likes to say that she now enjoys the privilege of full-time motherhood with the challenge of a full-time medical practice. When her schedule permits, Dr. Boone enjoys working in her art studio as an artisanal soap maker and painter. Dr. Boone is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Infant Hearing Loss.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wedner's expertise for a condition
ConditionClose
    • Distinguished
    • Bloom Syndrome
      Dr. Wedner is
      Distinguished
      . Learn about Bloom Syndrome.
      See more Bloom Syndrome experts
    • Common Variable Immune Deficiency
      Dr. Wedner is
      Distinguished
      . Learn about Common Variable Immune Deficiency.
      See more Common Variable Immune Deficiency experts
    • Primary Immunodeficiency (PID)
      Dr. Wedner is
      Distinguished
      . Learn about Primary Immunodeficiency (PID).
      See more Primary Immunodeficiency (PID) experts
    • Urticaria Pigmentosa
      Dr. Wedner is
      Distinguished
      . Learn about Urticaria Pigmentosa.
      See more Urticaria Pigmentosa experts
    • Advanced
    • Allergic Rhinitis
      Dr. Wedner is
      Advanced
      . Learn about Allergic Rhinitis.
      See more Allergic Rhinitis experts
    • Angioedema
      Dr. Wedner is
      Advanced
      . Learn about Angioedema.
      See more Angioedema experts
    • Asthma
      Dr. Wedner is
      Advanced
      . Learn about Asthma.
      See more Asthma experts
    • Asthma in Children
      Dr. Wedner is
      Advanced
      . Learn about Asthma in Children.
      See more Asthma in Children experts
    • Chronic Spontaneous Urticaria (CSU)
      Dr. Wedner is
      Advanced
      . Learn about Chronic Spontaneous Urticaria (CSU).
      See more Chronic Spontaneous Urticaria (CSU) experts
    • Grass Allergy
      Dr. Wedner is
      Advanced
      . Learn about Grass Allergy.
      See more Grass Allergy experts
    View All 10 Advanced Conditions
    • Experienced
    • Acute Eosinophilic Pneumonia
      Dr. Wedner is
      Experienced
      . Learn about Acute Eosinophilic Pneumonia.
      See more Acute Eosinophilic Pneumonia experts
    • Allergic Conjunctivitis
      Dr. Wedner is
      Experienced
      . Learn about Allergic Conjunctivitis.
      See more Allergic Conjunctivitis experts
    • Anaphylaxis
      Dr. Wedner is
      Experienced
      . Learn about Anaphylaxis.
      See more Anaphylaxis experts
    • Chronic Cough
      Dr. Wedner is
      Experienced
      . Learn about Chronic Cough.
      See more Chronic Cough experts
    • Complement Component 2 Deficiency
      Dr. Wedner is
      Experienced
      . Learn about Complement Component 2 Deficiency.
      See more Complement Component 2 Deficiency experts
    • Exercise-Induced Anaphylaxis (EIA)
      Dr. Wedner is
      Experienced
      . Learn about Exercise-Induced Anaphylaxis (EIA).
      See more Exercise-Induced Anaphylaxis (EIA) experts
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved